NCT07655258

Brief Summary

Patellofemoral pain syndrome (PFPS) is among the most prevalent forms of knee discomfort. The main complaint is typically anterior knee pain, which gets worse while jumping, bending knee, going up or down stairs, or sitting for long periods of time with bent knee. Teens and early adulthood are commonly affected by patellofemoral pain syndrome, with a higher frequency in females. In healthy general populations, the prevalence of patellofemoral pain syndrome is 22.7%, and in teens, it is 28.9%.

Trial Health

65
Monitor

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
60

participants targeted

Target at P25-P50 for not_applicable

Timeline
2mo left

Started Jun 2026

Shorter than P25 for not_applicable

Status
not yet recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

June 12, 2026

Completed
5 days until next milestone

First Posted

Study publicly available on registry

June 17, 2026

Completed
3 days until next milestone

Study Start

First participant enrolled

June 20, 2026

Expected
2 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

August 31, 2026

Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

August 31, 2026

Last Updated

June 17, 2026

Status Verified

June 1, 2026

Enrollment Period

2 months

First QC Date

June 12, 2026

Last Update Submit

June 12, 2026

Conditions

Keywords

Patellofemoral pain syndromehigh-intensity laser acupunctureFunctionpatient satisfaction

Outcome Measures

Primary Outcomes (1)

  • Pain Intensity

    The visual analogue scale represents the pain range that a patient thinks they might experience. The line is typically 10 centimetres long, with or without markings at each centimetre serves as a representation of the range. The worst pain the patient could possibly envision is represented by one end, while; no pain; is represented by the other. The patient marks the scale by drawing a line on it to indicate the amount of discomfort they are experiencing from 0-10. Higher scores represent worse pain.

    4 weeks

Secondary Outcomes (2)

  • Function of knee joint

    4 weeks

  • patient Satisfaction

    4 weeks

Study Arms (2)

high-intensity laser acupuncture and exercise therapy program.

EXPERIMENTAL

The patients will receive high-intensity laser acupuncture and exercise therapy program.three times a week for four weeks.

Device: high-intensity laser acupuncture and Exercise therapy program

sham laser acupuncture and exercise therapy program.

SHAM COMPARATOR

The patients will receive sham acupuncture laser and exercise therapy program three times a week for four weeks.

Other: Sham laser acupuncture

Interventions

The experimental group will receive high-intensity lasers and the treatment will be applied at over six points (ST34, ST 35, GB34, EX-LE4, SP9, and SP10) Exercise therapy program consisted of stretching for hamstring, gastrocnemius and iliotibial band, and strengthening exercises, which include isometric quadriceps exercises, straight leg raising, lateral straight leg raise, isometric hip adduction and squat to 30° knee flexion, 3 times /week for 4 weeks

Also known as: high-power laser acupuncture
high-intensity laser acupuncture and exercise therapy program.

Sham laser acupuncture and exercise therapy Program. Exercise therapy program consisted of stretching for hamstring, gastrocnemius and iliotibial band, and strengthening exercises, which include isometric quadriceps exercises, straight leg raising, lateral straight leg raise, isometric hip adduction and squat to 30° knee flexion, 3 times /week for 4 weeks

sham laser acupuncture and exercise therapy program.

Eligibility Criteria

Age18 Years - 25 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64)

You may qualify if:

  • Patients with patellofemoral pain syndrome (positive Clarkes sign and Waldron test)
  • Age from 18 to 25 years
  • Patients suffering from pain which aggravated by prolonged sitting, stair climbing, running, squatting, kneeling, hopping\\jumping, overuse activities and relieved by rest for at least 3 months
  • Visual analog scale (VAS) greater than 3 points in daily activity
  • The ability to participate in the study and follow the treatment schedule.

You may not qualify if:

  • Physiotherapy in the last 12 months
  • Intra-articular injection in the last 3 months
  • Other knee disorders such as: (osteoarthritis, previous knee surgery, history of knee arthroplasty, or traumatic injury related joint deformity)
  • BMI greater than or equal 30
  • Pregnancy
  • Pacemaker insertion
  • Photosensitivity
  • History of using oral analgesic or NSAIDs in the previous 4 weeks,
  • History of malignancy, psychiatric disorder, mental retardation, neurologic dysfunction, diabetes mellitus, or uncontrolled hypertension.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

MeSH Terms

Conditions

Patellofemoral Pain SyndromePatient Satisfaction

Condition Hierarchy (Ancestors)

Joint DiseasesMusculoskeletal DiseasesTreatment Adherence and ComplianceHealth BehaviorBehavior

Central Study Contacts

Doaa A Elimy, lecturer

CONTACT

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
DOUBLE
Who Masked
PARTICIPANT, OUTCOMES ASSESSOR
Masking Details
random generator
Purpose
TREATMENT
Intervention Model
PARALLEL
Model Details: high-intensity laser acupuncture and exercise therapy program
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Lecturer of physical therapy for basic science department., faculty of physical Therapy

Study Record Dates

First Submitted

June 12, 2026

First Posted

June 17, 2026

Study Start (Estimated)

June 20, 2026

Primary Completion (Estimated)

August 31, 2026

Study Completion (Estimated)

August 31, 2026

Last Updated

June 17, 2026

Record last verified: 2026-06